4 ms·
So... this involves injecting live (but injured) cancer cells back into the body? I think this is going to be hard to get approved.
by pfdietz 5y ago
So... this involves injecting live (but injured) cancer cells back into the body?
I think this is going to be hard to get approved.
- arrosenberg 5y agoThat was the methodology for the research. The paper shows that specifc types of chemotherapy related damage can trigger desirable immunological responses, so I'd guess the end goal would be a regular chemotherapy regimen that trigger that response. The end of the abstract hints at that by saying the research provides a strategy for increased efficacy, rather than claiming to be a potential treatment or adjuvant.